BIOCON Fundamental Report

SHARE PRICE

Get to know the company overview of BIOCON - face value, book value, exchange symbol, 1 year & lifetime highs/lows, average volume, market cap, PE ratio, 1 month return, % promoter holding pledged before investing in BIOCON

Current Price (Rs.) 254.70
Face Value (Rs.) 5
Book Value (Rs.) 55.89
52 Week High (Rs.) 341.22 (25-Jan-19)
52 Week Low (Rs.) 211.05 (20-Aug-19)
Life Time high (Rs.) 359.00 (26-Sep-18)
Life Time low (Rs.) 14.17 (02-Dec-08)
Exchange Symbol BIOCON (NSE)
Average Daily Movement [ADM] 8.29
Average Volume [20 days](No. of shares) 3937958
Market Cap (Rs. in Cr) 30564.00 (Cr)
1 Month Return (%) -2.15
P/E Ratio (x) 34.61
% of Promoter holding pledged 0.00

SHARE PRICE CHART

We recommend to use only Weekly and Monthly charts. Daily charts are also given which are used for exits.

We do not recommend daily/intraday minute hourly charts.

Why should you follow Weekly & Monthly levels - The major levels come from weekly and monthly charts which the FII, fund managers usually use for entry and profit booking.

BIOCON, NSE, INDIA

FUTURE BIOCON, NSE, INDIA

 

QUARTERLY RESULTS

Sep-19 Jun-19 Mar-19 Dec-18 Sep-18 Jun-18
Quarterly Quarterly Quarterly Quarterly Quarterly Quarterly
Source Of Info (AR = Annual Report, PR = Press Release)
Net Sales/Income from operations
Other Operating Income
Total Income From Operations
Increase/Decrease in Stocks
Consumption of Raw Materials
Purchase of Traded Goods
Employees Cost
Depreciation
Other Expenses
Total Expenditure
Operating Profit
Other Income
P/L Before Int., Excpt. Items & Tax
Interest
P/L Before Exceptional Items & Tax
Exceptional Item
P/L Before Tax
Tax
P/L After Tax from Ordinary Activities
Extra Ordinary Items
PAT
Minority Interest
Share Of P/L Of Associates
Net Profit/(Loss) For the Period
Equity Share Capital
Reserves
Equity Dividend Rate (%)
EPS (Rs.) [After Extraordinary items]
EPS (Rs.) [Before Extraordinary items]
 

RATIO ANALYSIS

Among all the ratios these are the most important ratios to look before investing in a company.
Get the latest key Financial Ratios and the Ratio Analysis of to gauge the overall financial health of a company before investing.

Name Ratio Good/Not Good Description
Current Ratio (x) 1.31 > 2 is Good,
< 2 is Not Good
A liquidity ratio that measures a companys ability to pay short-term obligations. The higher the current ratio, the more capable the company is of paying its obligations.
Quick Ratio (x) 0.94 > 1 is Good,
< 1 is Not Good
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets
Dividend Yield (%) 0.13 > 1.5 is Good,
< 1.5 is Not Good
A financial ratio that shows how much a company pays out in dividends each year relative to its share price. Dividend yield is calculated as annual dividends per share divided by market price per share.
Interest Coverage Ratio (x) 21.69 > 2 is Good,
< 2 is Not Good
(For Banks & NBFC this is not Valid)
It is used to determine how easily a company can pay interest on outstanding debt. It is calculated by dividing a companys EBIT by the interest expenses.
Debt Equity Ratio (x) 0.30 < 2 is Good,
> 2 is Not Good
(For Banks & NBFC this is not Valid)
A measure of a companys financial leverage calculated by dividing its total liabilities by stockholders equity. The debt/equity ratio also depends on the industry in which the company operates.
Return On Asset (%) 8.15 > 5% is Good,
< 5% is Not Good
An indicator of how efficient management is at using its assets to generate earnings. Calculated by dividing a companys annual earnings by its total assets
Return On Equity (%) 14.84 > 18% is Good,
< 18% is Not Good
Also called Return on networth, it measures a companys profitability by revealing how much profit a company generates with the money shareholders have invested, it is calculated by dividing the net profit after tax by shareholder's fund For high growth companies you should expect a higher ROE.

For investors interested in BIOCON find all important information on BIOCON share price, peer comparison and analysis.

 

DIVIDEND

 

Get a glimpse into the dividend history-payout amount of BIOCON, interim dividend and the latest dividend announcements by BIOCON in the last 5 years.

# Announcement Date Ex-Date Amount Interim/Final
1 25-Apr-2019 18-Jul-2019 0.50 Final
2 26-Apr-2018 19-Jul-2018 1.00 Final
3 02-May-2017 20-Jul-2017 1.00 Final
4 08-Mar-2016 17-Mar-2016 5.00 Interim
5 27-Mar-2015 09-Apr-2015 5.00 Interim
6 25-Apr-2014 10-Jul-2014 5.00 Final
7 26-Apr-2013 11-Jul-2013 7.50 Final&Spl
8 27-Apr-2012 05-Jul-2012 5.00 Final
9 28-Apr-2011 07-Jul-2011 3.00 Final
10 24-Apr-2011 05-May-2011 1.50 Interim
11 29-Apr-2010 08-Jul-2010 3.50 Final
 

PROMOTER SHAREHOLDING

Look up all relevant information on shareholding pattern of BIOCON, the change in shareholding as compared to last quarter, Promoters shareholding%, persons holding more than 1% shares of the company.

Shareholding PatternSep-19Jun-19Jun-19Mar-19Dec-18
Promoter and Promoter Group (%)60.6760.6760.6760.6761.48
Indian39.7739.7739.7739.7740.58
Foreign20.9020.9020.9020.9020.90
Institutions (%)20.7620.7221.4322.2822.07
FII15.7516.4316.5217.9017.59
DII5.014.294.924.384.48
NonInstitutions (%)18.5818.6117.9017.0616.45
Bodies CorporateNILNILNILNILNIL
Others17.2517.2716.5315.6215.16
Custodians1.331.341.361.431.29
Total no. of shares (cr.)120.00120.00120.0060.0060.00
 

PUBLIC SHAREHOLDING

Study of the shareholding pattern of a company is a very important part of fundamental analysis. The shareholding pattern is a determinant of the market capitalization of the stock and is an indicator of whether the stock valuation is justified or not. Know the Public shareholding % for the last quarter as announced by the company.

Persons holding securities more than 1% of total number of shares under category Public Shareholding.CategoryDec-16Sep-16Jun-16Mar-16Mar-17
Kiran Mazumdar ShawPromoters1.751.75NILNIL39.64
GLENTEC INTERNATIONALPromoters19.7719.77NILNIL19.77
OPPENHEIMER DEVELOPING MARKETS FUNDNonPromoters2.02NILNILNIL2.19
TrustsNonPromoters2.142.14NILNIL2.14
Bodies CorporateNonPromoters1.041.19NILNIL2.05
KIRAN MAZUMDAR SHAWNonPromotersNIL39.64NILNIL1.75
FRANKLIN TEMPLETON INVESTMENT FUNDSNonPromoters1.812.052.58NIL1.71
ARUN SURESH CHANDAVARKARNonPromoters1.101.10NILNIL1.10
MURALI KRISHNAN K NNonPromoters1.051.05NILNILNIL
Glentec InternationalPromotersNILNIL19.77NILNIL
Kiran Mazumdar Shaw- TrustNonPromotersNILNIL1.75NILNIL
SWISS FINANCE CORPORATION (MAURITIUS) LIMITEDNonPromotersNILNIL1.27NILNIL
TEMPLETON DEVELOPING MARKETS TRUSTNonPromotersNILNIL1.04NILNIL
Franklin Templeton Investment fundsNonPromotersNILNILNIL3.02NIL
LIC OF INDIA HEALTH PROTECTION PLUS FUNDNonPromotersNILNILNIL1.55NIL
RELIANCE CAPITAL TRUSTEE CO. LTDNonPromotersNILNILNIL1.23NIL
 

COMPANY PROFILE

Study BIOCON management, company profile, ownership, management, Board of Directors and Organization Structure of BIOCON

COMPANY PROFILE OF BIOCON, NSE, INDIA
Date of Incorporation 29-Nov-1978
Date of Listing 07-Apr-2004
Management
NameDesignation
Kiran Mazumdar Shaw Chairperson & Managing Director
Jeremy Levin Independent Director
Vijay Kuchroo Independent Director
Daniel M Bradbury Independent Director
Russel Walls Independent Director
Mary Harney Independent Director
M Damodaran Independent Director
Arun Chandavarkar Joint Managing Director & CEO
Ravi Mazumdar Non Executive Director
John Shaw Vice Chairman & Whole Time Dir
Registered Office Address
20th K.M. Hosur Road,Electronics City PO,Hebbagodi,, 560100, Bengaluru, Karnataka, India,
Website
http://www.biocon.com
 

PEERS PRICE COMPARISION

# Company Name Open High Low Last Price Prv Price Change % Chng
1 BIOCON 375.00 388.50 372.85 385.90 385.90 0 0.00
2 PFIZER 1728.80 1730.05 1711.00 1717.15 1717.15 0 0.00
3 BROOKS LAB 107.00 112.50 107.00 108.80 108.80 0 0.00
4 VIMTA LABS 128.40 130.40 128.40 129.00 129.00 0 0.00
5 JB CHEMICALS 280.25 283.15 275.00 275.90 275.90 0 0.00
6 SANOFI INDIA 4208.95 4230.00 4200.00 4213.30 4213.30 0 0.00
7 DISHMAN 288.20 304.20 278.00 301.20 301.20 0 0.00
8 MOREPEN LAB 16.75 17.00 16.50 16.60 16.60 0 0.00
9 NATCO PHARMA 995.95 995.95 983.00 986.70 986.70 0 0.00
10 ALKEM LABORATORIES 1841.00 1843.00 1821.00 1825.00 1825.00 0 0.00
11 SUVEN 222.05 230.40 218.10 221.15 221.15 0 0.00
12 GLAXO PHARMA 2464.00 2474.00 2436.30 2451.80 2451.80 0 0.00
13 PIRAMAL ENTERPRISES 2746.00 2774.90 2725.25 2761.50 2761.50 0 0.00
14 BLISS GVS 175.00 178.90 168.60 176.85 176.85 0 0.00
15 VENUS REMEDIES 104.05 104.15 103.00 103.50 103.50 0 0.00
16 JUBILANT 657.60 662.85 641.60 643.70 643.70 0 0.00
17 SHILPA MEDICARE 659.50 663.90 645.25 656.85 656.85 0 0.00
18 PROCTER GAMBLE HEALTH 1015.50 1072.00 1015.50 1064.30 1064.30 0 0.00
19 MARKSANS PHARMA 45.50 46.20 44.75 45.25 45.25 0 0.00
20 OPTO CIRCUITS 6.95 7.00 6.90 6.95 6.95 0 0.00
21 ALEMBIC PHARMA 500.00 501.70 497.00 500.30 500.30 0 0.00
22 SYNGENE 495.10 503.65 491.00 493.95 493.95 0 0.00
23 IPCA 500.00 503.45 493.00 495.55 495.55 0 0.00
24 RPG LIFE 387.55 405.00 387.55 396.80 396.80 0 0.00
25 CAPLIN POINT 700.40 707.50 690.20 697.90 697.90 0 0.00
26 KOPRAN 71.30 72.00 70.50 70.90 70.90 0 0.00
27 SPARC 370.40 374.80 365.50 367.85 367.85 0 0.00
28 FDC 183.10 188.10 183.10 186.75 186.75 0 0.00
29 NECTAR LIFESCIENCES 27.65 27.65 26.95 27.20 27.20 0 0.00

CIN: U67190WB2003PTC096617. Trading in Commodities is done through our Group Company Dynamic Commodities Pvt. Ltd. The company is also engaged in Proprietory Trading apart from Client Business.
“2019 © COPYRIGHT DYNAMIC EQUITIES PVT. LTD.”

Disclaimer: There is no guarantee of profits or no exceptions from losses. The investment advice provided are solely the personal views of the research team. You are advised to rely on your own judgment while making investment / Trading decisions. Past performance is not an indicator of future returns. Investment is subject to market risks. You should read and understand the Risk Disclosure Documents before trading/Investing.

Disclosure: We, Dynamic Equities Private Limited are also engaged in Proprietory Trading apart from Client Business. In case of any complaints/grievances, clients may write to us at compliance@dynamiclevels.com

  • Download our Mobile App
  • Available on Google Play
  • Available on App Store
  • RSS